
02 Feb 2022
AbbVie tops fourth-quarter estimates by ...
AbbVie (NYSE: ABBV) reports $3.31 EPS in the fourth quarter, which tops the $3.28 analyst estimate by $0.03. However, the company ...
Get access to the latest news, guides, stock and crypto updates, and take your financial portfolio to the next level.